Stephen Wilton
Director/Board Member bij BIOSYENT INC.
Vermogen: 16 679 $ op 31-03-2024
Profiel
Stephen Wilton is an Independent Director at BioSyent, Inc. since 2014.
Prior to this, he worked as an Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and as a Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
He completed his undergraduate degree at the University of Toronto and his MBA at The Schulich School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOSYENT INC.
0.02% | 27-03-2024 | 2 600 ( 0.02% ) | 16 679 $ | 31-03-2024 |
Actieve functies van Stephen Wilton
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSYENT INC. | Director/Board Member | 16-01-2014 |
Eerdere bekende functies van Stephen Wilton
| Bedrijven | Functie | Einde |
|---|---|---|
| The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01-01-2012 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | General Counsel | - |
Opleiding van Stephen Wilton
| University of Toronto | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| BioSyent, Inc. | |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| The Canadian Association of Chain Drug Stores |
